ArticleBlood cell therapy2023

GVHD relapse-free survival after peripheral blood hematopoietic cell transplantation for hematologic malignancies.

Deepesh P Lad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.